AI Article Synopsis

  • 2'-3-dimethyl-4-aminoazobenzene (OAT) is an azo dye identified as a potential human carcinogen by IARC, but its mechanism of action is not well understood.
  • Research indicates that OAT activates the Constitutive Androstane Receptor (CAR) in mice, leading to an increase in the expression of several CAR target genes in a dose-dependent manner.
  • CAR plays a crucial role in mediating the effects of OAT, as mice lacking CAR did not show the same gene expression changes, and while OAT did not immediately induce liver cell proliferation, it later caused a CAR-dependent proliferative response.

Article Abstract

2'-3-dimethyl-4-aminoazobenzene (ortho-aminoazotoluene, OAT) is an azo dye and a rodent carcinogen that has been evaluated by the International Agency for Research on Cancer (IARC) as a possible (class 2B) human carcinogen. Its mechanism of action remains unclear. We examined the role of the xenobiotic receptor Constitutive Androstane Receptor (CAR, NR1I3) as a mediator of the effects of OAT. We found that OAT increases mouse CAR (mCAR) transactivation in a dose-dependent manner. This effect is specific because another closely related azo dye, 3'-methyl-4-dimethyl-aminoazobenzene (3'MeDAB), did not activate mCAR. Real-time Q-PCR analysis in wild-type C57BL/6 mice revealed that OAT induces the hepatic mRNA expression of the following CAR target genes: Cyp2b10, Cyp2c29, Cyp3a11, Ugt1a1, Mrp4, Mrp2 and c-Myc. CAR-null (Car(-/-)) mice showed no increased expression of these genes following OAT treatment, demonstrating that CAR is required for their OAT dependent induction. The OAT-induced CAR-dependent increase of Cyp2b10 and c-Myc expression was confirmed by Western blotting. Immunohistochemistry analysis of wild-type and Car(-/-) livers showed that OAT did not acutely induce hepatocyte proliferation, but at much later time points showed an unexpected CAR-dependent proliferative response. These studies demonstrate that mCAR is an OAT xenosensor, and indicate that at least some of the biological effects of this compound are mediated by this nuclear receptor.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148291PMC
http://dx.doi.org/10.1016/j.taap.2011.05.019DOI Listing

Publication Analysis

Top Keywords

constitutive androstane
8
androstane receptor
8
target genes
8
oat
8
azo dye
8
analysis wild-type
8
mcar
5
ortho-aminoazotoluene activates
4
activates mouse
4
mouse constitutive
4

Similar Publications

Constitutive androstane receptor (CAR) is a xenosensor that is almost exclusively expressed in the liver. Studies in rodents suggest an oncogenic role for CAR in liver cancer, but its role in human liver cancer is unclear. We aimed to investigate the functional roles of CAR in human liver cancer with a focus on the liver cancer stem cells.

View Article and Find Full Text PDF

Contradictory Role of Gadd45β in Liver Diseases.

J Cell Mol Med

December 2024

Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

There are three homologous proteins (α, β and γ) in the growth arrest and DNA damage 45 (Gadd45) family. These proteins act as cellular responders to physiological and environmental stimuli. Gadd45β plays a significant role in the pathogenesis of liver diseases.

View Article and Find Full Text PDF

Development of BODIPY FL SNS 032 as a Versatile Probe for Constitutive Androstane Receptor and Multiple Kinases.

ACS Med Chem Lett

November 2024

Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Mail Stop 1000, Memphis, Tennessee 38105, United States.

Article Synopsis
  • - The human constitutive androstane receptor (hCAR) is important for regulating how the body breaks down foreign substances, but a method for studying its binding with various compounds was needed.
  • - Researchers identified the compound SNS-032 and its derivative THAL-SNS-032 as candidates that bind to hCAR, leading to the development of a fluorescent probe called BODIPY FL SNS-032 that can effectively measure these interactions.
  • - BODIPY FL SNS-032 not only binds strongly to hCAR (with a binding affinity of around 300 nM) but also has significant binding affinities to various kinases, making it a useful tool for studying both hCAR and kinase function.
View Article and Find Full Text PDF

Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney.

Eur J Drug Metab Pharmacokinet

November 2024

Changsha Research and Development Center on Obstetric and Gynecologic Traditional Chinese Medicine Preparation, NHC Key Laboratory of Birth Defects Research, Prevention and Treatment, Hunan Provincial Maternal and Child Health Care Hospital, No. 53 Xiangchun Road, Kaifu District, Changsha, 410008, Hunan, China.

Background And Objectives: Hypertensive nephropathy (HN) has become one of the main causes of end-stage renal disease. Drug combination therapy is a common clinical treatment for HN. However, the impact of HN on drug-metabolizing enzymes and transporters, which may lead to drug-drug interactions (DDIs) and even trigger toxic side effects, remains unclear.

View Article and Find Full Text PDF

[Novel Regulatory Mechanisms for Expression of Drug Metabolism-related Factors].

Yakugaku Zasshi

November 2024

Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University.

Interindividual differences in the expression and activity of drug-metabolizing enzymes, including cytochrome P450, UDP-glucuronosyltransferase, and esterases, cause variability of therapeutic effectiveness and side effects during drug treatment. Conventional research has focused on transcriptional regulation by transcription factors and nuclear receptors such as aryl hydrocarbon receptor, pregnane X receptor (PXR), constitutive androstane receptor, and hepatocyte nuclear factor 4α, as the major mechanisms causing the differences in the expression of drug-metabolizing enzymes. Recently, we have revealed that adenosine-to-inosine RNA editing and methylation of adenosine at the N position on RNA, two major types of posttranscriptional modification, play a pivotal role in the regulation of drug metabolism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!